PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
1-Year Return
16.62%
This Quarter Return
+9.65%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.48B
AUM Growth
+$17.8M
(+0.72%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-4.32%
Top 10 Holdings %
Top 10 Hldgs %
64.83%
Holding
157
New
15
Increased
31
Reduced
63
Closed
18
Top Buys
| 1 |
Broadcom
AVGO
|
$135M |
| 2 |
ZTO Express
ZTO
|
$65.8M |
| 3 |
TransUnion
TRU
|
$16.5M |
| 4 |
Mobileye
MBLY
|
$15.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$4.92M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$81.8M |
| 2 |
Suzano
SUZ
|
$35.5M |
| 3 |
IDEAYA Biosciences
IDYA
|
$21.9M |
| 4 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
$21.8M |
| 5 |
XYZ
Block, Inc.
XYZ
|
$21.3M |
Sector Composition
| 1 | Technology | 19.71% |
| 2 | Energy | 16.06% |
| 3 | Consumer Discretionary | 15.49% |
| 4 | Industrials | 14.8% |
| 5 | Financials | 14.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
AnaptysBio
ANAB
$602M
| $1.49M | 0.06% |
+66,154
| New | +$1.49M |
|
77
Advanced Micro Devices
AMD
$260B
| $1.49M | 0.06% |
8,232
+1,394
| +20% | +$252K |
|
|
ALLK
78
DELISTED
Allakos
ALLK
| $1.48M | 0.06% |
1,172,061
+537,038
| +85% | +$677K |
|
79
Ryanair
RYAAY
$32.1B
| $1.46M | 0.06% |
25,000
| – | – |
|
80
Aura Biosciences
AURA
$393M
| $1.41M | 0.06% |
180,145
| – | – |
|
81
Analog Devices
ADI
$120B
| $1.38M | 0.06% |
6,965
-1,778
| -20% | -$352K |
|
82
Sarepta Therapeutics
SRPT
$1.92B
| $1.33M | 0.05% |
10,275
| – | – |
|
83
4D Molecular Therapeutics
FDMT
$287M
| $1.3M | 0.05% |
+40,767
| New | +$1.3M |
|
84
Cogent Biosciences
COGT
$1.81B
| $1.25M | 0.05% |
186,254
-289,380
| -61% | -$1.94M |
|
85
Salesforce
CRM
$231B
| $1.16M | 0.05% |
+3,862
| New | +$1.16M |
|
86
Cytokinetics
CYTK
$5.91B
| $1.13M | 0.05% |
16,126
-3,012
| -16% | -$211K |
|
87
Qualcomm
QCOM
$171B
| $1.12M | 0.05% |
6,636
-596
| -8% | -$101K |
|
88
Prothena Corp
PRTA
$445M
| $1.03M | 0.04% |
41,508
| – | – |
|
89
Kura Oncology
KURA
$697M
| $998K | 0.04% |
+46,789
| New | +$998K |
|
|
CNTG
90
DELISTED
Centogene N.V. Common Shares
CNTG
| $842K | 0.03% |
1,186,102
-1,190,340
| -50% | -$845K |
|
91
Codexis
CDXS
$212M
| $802K | 0.03% |
+229,667
| New | +$802K |
|
92
Cadence Design Systems
CDNS
$95.1B
| $563K | 0.02% |
1,808
| – | – |
|
93
Sagimet Biosciences
SGMT
$233M
| $491K | 0.02% |
90,633
-21,119
| -19% | -$114K |
|
|
BPMC
94
DELISTED
Blueprint Medicines
BPMC
| $476K | 0.02% |
5,018
| – | – |
|
95
Match Group
MTCH
$9.01B
| $464K | 0.02% |
+12,780
| New | +$464K |
|
96
Biogen
BIIB
$20.1B
| $461K | 0.02% |
2,140
-21,880
| -91% | -$4.72M |
|
97
Core & Main
CNM
$12.3B
| $406K | 0.02% |
+7,084
| New | +$406K |
|
98
Freeport-McMoran
FCX
$65.7B
| $382K | 0.02% |
8,124
+3,461
| +74% | +$163K |
|
|
99
Suzano
SUZ
$11.7B
| $375K | 0.02% |
29,319
-2,780,681
| -99% | -$35.5M |
|
100
Ero Copper
ERO
$1.5B
| $362K | 0.01% |
18,738
+2,564
| +16% | +$49.5K |
|